3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy cores.
Reguly
Brian
B
Genesis Genomics Inc., Thunder Bay, ON;
Jakupciak
John P
JP
Parr
Ryan L
RL